5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one

C92H85F8N17O4 — CID 167700649

IUPAC5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one
SMILESC=C(c1ccc2c(-c3ccc4c(=O)[nH]ccc4c3)n(C)nc2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(=O)[nH]ncc4c3)nn(C)c2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(c3)CNC4=O)n[nH]c2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(c3)CNC4=O)nn(C)c2c1)N1CCC(F)(F)CC1
InChIInChI=1S/C24H22F2N4O.C23H21F2N5O.C23H22F2N4O.C22H20F2N4O/c1-15(30-11-8-24(25,26)9-12-30)16-3-6-20-21(14-16)28-29(2)22(20)18-4-5-19-17(13-18)7-10-27-23(19)31;1-14(30-9-7-23(24,25)8-10-30)15-3-6-19-20(12-15)29(2)28-21(19)16-4-5-18-17(11-16)13-26-27-22(18)31;1-14(29-9-7-23(24,25)8-10-29)15-3-6-19-20(12-15)28(2)27-21(19)16-4-5-18-17(11-16)13-26-22(18)30;1-13(28-8-6-22(23,24)7-9-28)14-2-5-18-19(11-14)26-27-20(18)15-3-4-17-16(10-15)12-25-21(17)29/h3-7,10,13-14H,1,8-9,11-12H2,2H3,(H,27,31);3-6,11-13H,1,7-10H2,2H3,(H,27,31);3-6,11-12H,1,7-10,13H2,2H3,(H,26,30);2-5,10-11H,1,6-9,12H2,(H,25,29)(H,26,27)
InChIKeyYIICGNGCQNVHBJ-UHFFFAOYSA-N
MW1644.79 g/mol
LogP17.32
Rot. Bonds12

About 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one

5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one (PubChem CID 167700649) has the molecular formula C92H85F8N17O4 and a molecular weight of 1644.79 g/mol. Its IUPAC name is 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one.

Molecular Properties

Compound Name5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one
PubChem CID167700649
Molecular FormulaC92H85F8N17O4
Molecular Weight1644.79 g/mol
Exact Mass1643.68
IUPAC Name5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one
SMILESC=C(c1ccc2c(-c3ccc4c(=O)[nH]ccc4c3)n(C)nc2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(=O)[nH]ncc4c3)nn(C)c2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(c3)CNC4=O)n[nH]c2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(c3)CNC4=O)nn(C)c2c1)N1CCC(F)(F)CC1
InChIInChI=1S/C24H22F2N4O.C23H21F2N5O.C23H22F2N4O.C22H20F2N4O/c1-15(30-11-8-24(25,26)9-12-30)16-3-6-20-21(14-16)28-29(2)22(20)18-4-5-19-17(13-18)7-10-27-23(19)31;1-14(30-9-7-23(24,25)8-10-30)15-3-6-19-20(12-15)29(2)28-21(19)16-4-5-18-17(11-16)13-26-27-22(18)31;1-14(29-9-7-23(24,25)8-10-29)15-3-6-19-20(12-15)28(2)27-21(19)16-4-5-18-17(11-16)13-26-22(18)30;1-13(28-8-6-22(23,24)7-9-28)14-2-5-18-19(11-14)26-27-20(18)15-3-4-17-16(10-15)12-25-21(17)29/h3-7,10,13-14H,1,8-9,11-12H2,2H3,(H,27,31);3-6,11-13H,1,7-10H2,2H3,(H,27,31);3-6,11-12H,1,7-10,13H2,2H3,(H,26,30);2-5,10-11H,1,6-9,12H2,(H,25,29)(H,26,27)
InChIKeyYIICGNGCQNVHBJ-UHFFFAOYSA-N
XLogP17.32
TPSA231.91 Ų
H-Bond Donors5
H-Bond Acceptors16
Rotatable Bonds12
Heavy Atoms121
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001644.79
LogP ≤ 517.32
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1016

Analyze 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-[2-[9-[4-[(6S,8R)-7-(2,2-difluoroethyl)-8-methyl-3,6,8,9-tetrahydropyrazolo[4,5-f]isoquinolin-6-yl]-3,5-difluorophenyl]-3,9-diazaspiro[5.5]undecan-3-yl]-2-oxoethyl]-2-(2,6-dioxopiperidin-3-yl)-5,7-dihydropyrrolo[3,4-f]isoindole-1,3-dione
CID 164924072
6-[2-[9-[3,5-difluoro-4-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-3,6,8,9-tetrahydropyrazolo[4,5-f]isoquinolin-6-yl]phenyl]-3,9-diazaspiro[5.5]undecan-3-yl]-2-oxoethyl]-2-(2,6-dioxopiperidin-3-yl)-5,7-dihydropyrrolo[3,4-f]isoindole-1,3-dione
CID 172444336
N-[5-[3-[4-(4-fluorophenyl)-1H-indol-2-yl]-7-[2-fluoro-5-[2-[5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-pyrazolo[4,3-b]pyridin-3-yl]-1H-indol-4-yl]phenyl]-1H-pyrazolo[4,3-b]pyridin-5-yl]-3-pyridinyl]benzamide
CID 137087958
N-[5-[3-[4-(4-fluorophenyl)-1H-indol-2-yl]-7-[2-fluoro-5-[2-[5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-pyrazolo[3,4-c]pyridin-3-yl]-1H-indol-4-yl]phenyl]-1H-pyrazolo[3,4-c]pyridin-5-yl]-3-pyridinyl]benzamide
CID 137102862
2-[3-(difluoromethyl)-4,4,7,7-tetrafluoro-5,6-dihydroindazol-1-yl]-N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(2-methyl-1-oxo-3H-isoindol-5-yl)-2-pyridinyl]ethyl]propanamide;3-[2-[(1S)-2-(3,5-difluorophenyl)-1-[2-[3-(trifluoromethyl)pyrazol-1-yl]propanoylamino]ethyl]-3-pyridinyl]-N-methylbenzamide;3-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[2-(3,4,5-trimethylpyrazol-1-yl)acetyl]amino]ethyl]-3-pyridinyl]-N-methylbenzamide
CID 157076869
5-(5-amino-3-pyridinyl)-N-[6-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[(dimethylamino)methyl]-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide
CID 157165576
(4R)-4-[3-[3-(1-aminoethenyl)-4-fluorophenyl]-2-pyridinyl]-5-(3,5-difluorophenyl)-1-[4,4-difluoro-3-(trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1-yl]pentan-2-one;5-[2-[(2R)-5-(5,6-difluoro-1H-indol-3-yl)-1-(3,5-difluorophenyl)-4-oxopentan-2-yl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;5-[2-[(2R)-5-(5,7-difluoro-1H-indol-3-yl)-1-(3,5-difluorophenyl)-4-oxopentan-2-yl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;(4R)-5-(3,5-difluorophenyl)-1-(4-methyl-1H-indol-3-yl)-4-[3-(4-methylphenyl)-2-pyridinyl]pentan-2-one
CID 157243696
(4R)-4-[3-[3-(1-aminoethenyl)-4-fluorophenyl]-2-pyridinyl]-5-(3,5-difluorophenyl)-1-[3-(trifluoromethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]pentan-2-one;(4R)-1-[3,5-bis(difluoromethyl)pyrazol-1-yl]-4-[3-(7H-cyclopenta[b]pyridin-3-yl)-2-pyridinyl]-5-(3,5-difluorophenyl)pentan-2-one;5-[2-[(2R)-5-cyclopentyl-1-(3,5-difluorophenyl)-4-oxo-5-phenylpentan-2-yl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;(4R)-5-(3,5-difluorophenyl)-4-[3-(4-methylphenyl)-2-pyridinyl]-1-[5-(trifluoromethyl)-1H-indol-3-yl]pentan-2-one;5-[2-[(2R)-1-(3,5-difluorophenyl)-4-oxo-5-pyrrolo[3,2-c]pyridin-1-ylpentan-2-yl]-3-pyridinyl]-2-fluoro-N-methylbenzamide
CID 157245939
3-[1-cyclopentyl-3-(trifluoromethyl)pyrazol-5-yl]-N,N-dimethylbenzamide;N,N-dimethyl-3-[1-propan-2-yl-5-(trifluoromethyl)pyrazol-3-yl]benzamide;[3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]phenyl]-piperidin-1-ylmethanone;piperidin-1-yl-[3-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenyl]methanone;piperidin-1-yl-[4-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenyl]methanone
CID 157261189
5-[2-[(1S)-1-[[(2S)-2-(3-acetylindol-1-yl)butanoyl]amino]-2-(3,5-difluorophenyl)ethyl]-3-pyridinyl]-2-fluorobenzamide;5-[2-[(1S)-1-[[(2R)-2-(3-acetylindol-1-yl)butanoyl]amino]-2-(3,5-difluorophenyl)ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[(2R)-2-[5,6-dimethyl-3-(trifluoromethyl)indazol-1-yl]butanoyl]amino]ethyl]-3-pyridinyl]-2-fluorobenzamide;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[(2S)-2-[5,6-dimethyl-3-(trifluoromethyl)indazol-1-yl]butanoyl]amino]ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[(2S)-2-[4-(trifluoromethyl)pyrazol-1-yl]butanoyl]amino]ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide
CID 157314839
N-[2-(diethylamino)ethyl]-N-(1H-inden-4-ylmethyl)-5-methyl-1H-pyrazole-3-carboxamide;N-[2-(diethylamino)ethyl]-N-(3H-indol-7-ylmethyl)-5-methyl-1H-pyrazole-3-carboxamide;N-(1H-inden-4-ylmethyl)-N-(2-pyrrolidin-1-ylethyl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide;N-(1H-indol-7-ylmethyl)-N-(2-pyrrolidin-1-ylethyl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide
CID 157517013
1-(aminomethyl)-7-(1,3-dimethylpyrazol-4-yl)-3H-isoquinolin-4-one;1-(aminomethyl)-7-(5-methyl-1H-pyrazol-3-yl)-3H-isoquinolin-4-one;1-(aminomethyl)-7-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-3H-isoquinolin-4-one;1-(aminomethyl)-7-(1-propylpyrazol-4-yl)-3H-isoquinolin-4-one;1-(aminomethyl)-7-(1,3,5-trimethylpyrazol-4-yl)-3H-isoquinolin-4-one;4-ethyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2H-phthalazin-1-one
CID 157517367

Frequently Asked Questions

What is the IUPAC name of 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one?
The IUPAC name of 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one (CID 167700649) is 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one.
What is the SMILES notation for 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one?
The canonical SMILES for 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one is C=C(c1ccc2c(-c3ccc4c(=O)[nH]ccc4c3)n(C)nc2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(=O)[nH]ncc4c3)nn(C)c2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(c3)CNC4=O)n[nH]c2c1)N1CCC(F)(F)CC1.C=C(c1ccc2c(-c3ccc4c(c3)CNC4=O)nn(C)c2c1)N1CCC(F)(F)CC1.
What is the InChIKey of 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one?
The InChIKey is YIICGNGCQNVHBJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H22F2N4O.C23H21F2N5O.C23H22F2N4O.C22H20F2N4O/c1-15(30-11-8-24(25,26)9-12-30)16-3-6-20-21(14-16)28-29(2)22(20)18-4-5-19-17(13-18)7-10-27-23(19)31;1-14(30-9-7-23(24,25)8-10-30)15-3-6-19-20(12-15)29(2)28-21(19)16-4-5-18-17(11-16)13-26-27-22(18)31;1-14(29-9-7-23(24,25)8-10-29)15-3-6-19-20(12-15)28(2)27-21(19)16-4-5-18-17(11-16)13-26-22(18)30;1-13(28-8-6-22(23,24)7-9-28)14-2-5-18-19(11-14)26-27-20(18)15-3-4-17-16(10-15)12-25-21(17)29/h3-7,10,13-14H,1,8-9,11-12H2,2H3,(H,27,31);3-6,11-13H,1,7-10H2,2H3,(H,27,31);3-6,11-12H,1,7-10,13H2,2H3,(H,26,30);2-5,10-11H,1,6-9,12H2,(H,25,29)(H,26,27).
What are the key properties of 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one?
5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one has a molecular weight of 1644.79 g/mol, XLogP of 17.32, 12 rotatable bonds, 5 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1H-indazol-3-yl]-2,3-dihydroisoindol-1-one;5-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2,3-dihydroisoindol-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-2-methylindazol-3-yl]-2H-isoquinolin-1-one;6-[6-[1-(4,4-difluoropiperidin-1-yl)ethenyl]-1-methylindazol-3-yl]-2H-phthalazin-1-one is sourced from PubChem (CID 167700649), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).